Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)
- Substances:BortezomibDexamethasone+4
Italy- Participants:0–17 years
- Substances:Bortezomib
- Sponsor:Charite Universitaetsmedizin Berlin KöR
Rare diseases
Investigational molecules
Locations
Back to Italy377 clinical trials in Ancona, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
ItalyStudy on Colchicine and Thiamine for Patients with Heart Failure from Ischemic Heart Disease
ItalyStudy on the Safety of ELGN-2112 for Preterm Infants with Intestinal Malabsorption
ItalyStudy of NVL-655 for Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors with ALK Mutation
ItalyStudy of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine
ItalyStudy on the Effectiveness and Safety of IgM-Enriched Immunoglobulin Therapy for Patients with Septic Shock
ItalyStudy on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination
ItalyStudy of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma
Italy
ItalyStudy on Zanidatamab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer After Trastuzumab Deruxtecan Treatment
ItalyStudy on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response
ItalyStudy on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on metastatic colorectal cancer and various advanced cancers including gastric cancer and non-small cell lung cancer. Studies evaluate novel treatment combinations and targeted therapies.
Multiple studies examining new therapeutic approaches for pancreatic adenocarcinoma and advanced solid tumors.
Comprehensive research into blood disorders, including multiple myeloma and chronic myeloid leukemia. Studies focus on novel treatment combinations and targeted therapies.
Evaluation of new therapeutic approaches for various blood cancers and related conditions.
Clinical studies investigating treatments for psoriatic arthritis, hidradenitis suppurativa, and atopic dermatitis. Focus on innovative biological therapies.
Research aimed at improving treatment outcomes for chronic inflammatory conditions.
Studies evaluating treatments for progressive pulmonary fibrosis and severe asthma. Research focuses on improving lung function and disease management.
Development of innovative therapies for chronic respiratory diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.